‘Collaboration is needed between pharmaceutical companies and governments to combat the spread of COVID-19 and accelerate access to tests, treatments and vaccines. Norway, which co-chairs the Facilitation Council of the ACT-Accelerator, is committed to ensuring the global vaccination effort is managed effectively. Here are four principles which could ensure equitable access to COVID-19 tools and health products, particularly for low and middle-income countries:
- Principle 1: File for registration rapidly, widely and on the basis of the most rigorous standards
- Principle 2: Price health technologies fairly
- Principle 3: Expand production and supply capacity
- Principle 4: Transparency
Read here (World Economic Forum, Feb 9, 2021)
